Table 3.
Univariate and multivariate analysis of different prognostic factors for disease specific survival in patients with LUAD.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
| Gender | 491 | ||||
| Female | 262 | Reference | |||
| Male | 229 | 0.989 (0.687-1.424) | 0.954 | ||
| Age | 481 | ||||
| ≤65 | 243 | Reference | |||
| >65 | 238 | 1.013 (0.701-1.464) | 0.944 | ||
| Pathologic stage | 483 | ||||
| Stage I & stage II | 389 | Reference | |||
| Stage III & stage IV | 94 | 2.436 (1.645-3.605) | <0.001 | 2.322 (1.562-3.450) | <0.001 |
| NPSR1-AS1 | 491 | ||||
| Low | 251 | Reference | |||
| High | 240 | 1.460 (1.013-2.105) | 0.043 | 1.370 (0.943-1.988) | 0.098 |